LifeMD, Inc. (LFMDP) Preferred Stock Liabilities (2020 - 2023)
LifeMD's (LFMDP) quarterly Preferred Stock Liabilities came in at $5.0 million in Q2 2023, up 16.06% YoY from $4.3 million in Q2 2022, and up 7.59% on a QoQ basis from $4.7 million in Q1 2023.
LifeMD, Inc. (LFMDP) Preferred Stock Liabilities (2020 - 2023) Analysis & Trends
LifeMD (LFMDP) has 4 years of Preferred Stock Liabilities data on file, last reported at $5.0 million in Q2 2023.
- Quarterly Preferred Stock Liabilities rose 16.06% year-over-year to $5.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $5.0 million (up 16.06% YoY) and the FY2022 annual result came in at $4.6 million, up 11.07% from the prior year.
- Preferred Stock Liabilities rose to $5.0 million in Q2 2023, from $4.7 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $5.0 million in Q2 2023 to a low of $3.7 million in Q4 2020.
- A 4-year average of $4.2 million and a median of $4.2 million in 2022 frame the typical range for Preferred Stock Liabilities.
- The widest YoY moves for Preferred Stock Liabilities: up 16.06% in 2023, down 10.77% in 2023.
- Tracing LFMDP's Preferred Stock Liabilities over 4 years: stood at $3.7 million in 2020, then advanced by 12.45% to $4.1 million in 2021, then increased by 11.07% to $4.6 million in 2022, then rose by 10.23% to $5.0 million in 2023.
- The last three Preferred Stock Liabilities figures came in at $5.0 million (Q2 2023), $4.7 million (Q1 2023), and $4.6 million (Q4 2022), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 5.03 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | 4.57 Mn |
| Sep 30, 2022 | 4.45 Mn |
| Jun 30, 2022 | 4.34 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 4.11 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 3.78 Mn |
| Dec 31, 2020 | 3.66 Mn |